Results 121 to 130 of about 41,111 (239)
ABSTRACT Objective To describe the clinical course and outcome of adjuvant topical mitomycin C (MMC) therapy following incomplete resection of a conjunctival amelanotic melanoma in a dog. Animals Studied A 15‐year‐old spayed‐female Shih Tzu presented with a conjunctival mass in the right eye (OD).
Junyeong Ahn +4 more
wiley +1 more source
ABSTRACT Objective Describe the clinical features, disease progression, and outcomes of presumed primary lens instability (PLI) in cats, and to assess its association with glaucoma. Animals Studied Thirty‐four cats (68 eyes). Procedures Medical records were reviewed for signalment, clinical history, ophthalmic findings, and treatment.
Havi Sarfaty +5 more
wiley +1 more source
Revisiting Polymyxin B: Pharmacokinetics, Biodistribution and Mechanism(s) of Intrarenal Transport [PDF]
Objectives: Despite dose-limiting nephrotoxic potentials, polymyxin B has re-emerged as the last line of therapy against multidrug-resistant Gram-negative bacterial infections.
Manchandani, Pooja
core
A direct comparison is made between circular dichroism (CD) spectroscopy and molecular dynamics (MD) simulations for studying peptide partitioning through biological membranes. The assumptions and limitations of each method is discussed, and case studies are provided for their use.
Cinzia Campus +5 more
wiley +1 more source
The prevalence of antibiotic resistance among Gram-negative bacteria, particularly Enterobacterales, is rising. Extensively drug-resistant (XDR) Enterobacterales demonstrate nonsusceptibility to all except two or fewer classes of antibiotics, where it ...
R. Kalaivani +2 more
doaj +1 more source
Optimisation of a Novel Class of DNA Gyrase Inhibitors to Improve Antibacterial Activity
This article describes efforts to increase the antibacterial activity of a recently reported class of novel DNA gyrase inhibitors known as the isoquinoline sulphonamides by improving their uptake in bacterial cells. As antibiotic resistance continues to rise, the need for new antibacterials is clear.
Meg I. Ferguson +9 more
wiley +1 more source
Objective: Intracranial infections caused by Acinetobacter baumannii (A. baumannii) are common and life-threatening. This study aimed to compare the clinical efficacy and risk factors associated with 30-d mortality rates between intravenous (IV ...
Li You +4 more
doaj +1 more source
In this study, we assessed the impact of commercially available polymyxin B against VRP-034 (novel formulation of polymyxin B) using a validated in vitro human renal model, aProximateTM. Freshly isolated primary proximal tubule cells (PTCs) were cultured
Keith Pye +4 more
doaj +1 more source
Antimicrobial prescribing guidelines for feedlot cattle
Australian Veterinary Journal, Volume 104, Issue 7, Page 413-438, July 2026.
P Cusack +4 more
wiley +1 more source
Polymyxin B adjuvants against polymyxin B- and carbapenem-resistant Gram-negative bacteria
Aim: Polymyxin B (PMB) is one of the few therapeutic options for treating infections caused by carbapenem-resistant Gram-negative bacteria (CR-GNB). However, the emergence of PMB-resistant CR-GNB strains has prompted the exploration of antibiotic adjuvants as potential therapeutic avenues.
João Paulo Salvaterra Pasquini +10 more
openaire +2 more sources

